Is leflunomide effective in the treatment of psoriasis in a patient who is unable to benefit from standard first- and second-line therapies and needs an affordable treatment option?
Affleck
Andrew Graeme
AG
epartments of Dermatology, Ninewells Hospital and Medical School, Dundee, Scotland.
Williams
Hywel
H
D019317:Evidence-Based Medicine; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D007555:Isoxazoles / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000077339:Leflunomide; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D055815:Young Adult
D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide